Literature DB >> 3904924

Autoradiography of high affinity uptake of catecholamines by primary astrocyte cultures.

D Semenoff, H K Kimelberg.   

Abstract

Uptake of D.L-[3H]norepinephrine ([3H]NE) and [3H]dopamine ([3H]DA) by primary astrocyte cultures prepared from neonatal rat brains, which are greater than or equal to 95% glial fibrillary acidic protein (GFAP(+)), was studied by measuring accumulation of tritium label, and localizing such uptake at the cellular level by autoradiography. Uptake of [3H]NE was 95% Na+ dependent at 10(-7) M and 80% Na+ dependent at 7.5 X 10(-7) M [3H]NE. Uptake of [3H]DA at 7.5 X 10(-7) M was 58% Na+ dependent, but total uptake of [3H]DA was greater than uptake of [3H]NE. Autoradiography of cells incubated with 7.5 X 10(-7) M [3H]NE or [3H]DA showed that a high proportion of all the cells in these cultures had a grain density which was clearly above background. When Na+ was omitted from the medium, the temperature was lowered to 4 degrees C, or 10(-7) M desmethylimipramine or 10(-7) M amitryptyline were present, cellular grain density after exposure to both [3H]NE and [3H]DA was greatly reduced, to close to background levels. It also appeared necessary to have inhibitors of both monoamine oxidase (pargyline) and catecholamine-O-methyltransferase (tropolone) present to see clear cellular localization for [3H]DA. In the case of [3H]NE the presence of tropolone alone was adequate to observe cellular localization. These results confirm our previous findings of the existence of a high affinity uptake process for catecholamines in primary astrocyte cultures based on uptake properties, and in the present study also localizes such uptake to the major, astrocytic cell type.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3904924     DOI: 10.1016/0006-8993(85)90368-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells.

Authors:  S Streich; M Brüss; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Evidence for functional separation of alpha-1 and alpha-2 noradrenaline receptors by pre-synaptic terminal re-uptake mechanisms.

Authors:  A J Clark; S P Butcher; P Winn
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Expression of preproenkephalin mRNA by cultured astrocytes and neurons.

Authors:  M H Vilijn; P J Vaysse; R S Zukin; J A Kessler
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 4.  Release studies related to the neurotransmitter role of glutamate in the cerebellum: an overview.

Authors:  G Levi; V Gallo
Journal:  Neurochem Res       Date:  1986-12       Impact factor: 3.996

Review 5.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  Dissociation of neonatal rat brain by dispase for preparation of primary astrocyte cultures.

Authors:  M V Frangakis; H K Kimelberg
Journal:  Neurochem Res       Date:  1984-12       Impact factor: 3.996

Review 7.  The role of oxidative stress in Parkinson's disease.

Authors:  Vera Dias; Eunsung Junn; M Maral Mouradian
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

8.  Glial alpha 2-receptors probably inhibit the high-affinity uptake of noradrenaline into astrocytes in the rat brain in vivo.

Authors:  G Köster
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

9.  Accumulation of noradrenaline and its oxidation products by cultured rodent astrocytes.

Authors:  J X Wilson; G A Wilson
Journal:  Neurochem Res       Date:  1991-11       Impact factor: 3.996

10.  Neuroprotective Role of Astroglia in Parkinson Disease by Reducing Oxidative Stress Through Dopamine-Induced Activation of Pentose-Phosphate Pathway.

Authors:  Kyoko Mashima; Shinichi Takahashi; Kazushi Minami; Yoshikane Izawa; Takato Abe; Naoki Tsukada; Takako Hishiki; Makoto Suematsu; Mayumi Kajimura; Norihiro Suzuki
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.